Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports the formation of targeted therapies by enabling selective binding to enzyme active sites. Commonly utilized in research settings for designing new active pharmaceutical ingredients (APIs) due to its halogenated aromatic framework, which enhances reactivity in cross-coupling reactions like Suzuki and Buchwald-Hartwig aminations. Also employed in the preparation of biologically active molecules in medicinal chemistry programs.